| ［1］ Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015［J］. CA Cancer J Clin, 2016, 66(2): 115132. DOI: 10.3322/caac.21338.
［2］ Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019［J］. CA Cancer J Clin, 2019, 69(1): 734. DOI: 10.3322/caac.21551.
［3］ Niu FY, Zhou Q, Yang JJ, et al. Distribution and prognosis of uncommon metastases from nonsmall cell lung cancer［J］. BMC Cancer, 2016, 16: 149. DOI: 10.1186/s1288501621695.
［4］ 郭爱萍, 陈曦. 老年肺癌伴子宫颈转移1例［J］. 临床肿瘤学杂志, 2008, 13(9): 864. DOI: 10.3969/j.issn.10090460.2008.09.027.
［5］ 张洁, 刘磊, 于佩瑶. 老年女性肺癌完全缓解后宫颈及子宫内膜转移一例［J］. 中国医药, 2013, 8(2): 263. DOI: 10.3760/cma.j.issn.16734777.2013.02.056.
［6］ Kai K, Takai N, Nasu K, et al. Metastatic uterine cervical cancer originating in the lung: a case report［J］. Gynecol Obstet Invest, 2009, 68(4): 269271. DOI: 10.1159/000241297.
［7］ Omrani A, Schnatz PF, Qi J, et al. Lung cancer metastatic to a cervical polyp［J］. Gynecol Oncol, 2004, 92(1): 2224. DOI: 10.1016/j.ygyno.2003.10.030.
［8］ Daw E. Extragenital adenocarcinoma metastatic to the cervix uteri［J］. Am J Obstet Gynecol, 1972, 114(8): 11041105. DOI: 10.1016/00029378(72)908812.
［9］ Izmajlowicz B, Kornafel J, Blaszczyk J. Multiple neoplasms among cervical cancer patients in the material of the lower Silesian cancer registry［J］. Adv Clin Exp Med, 2014, 23(3): 433440. DOI: 10.17219/acem/37141.
［10］ 张爱丽, 孙宇, 徐少艳, 等. 免疫组化在肺小活检中对鳞状细胞癌和腺癌的鉴别诊断意义［J］. 诊断病理学杂志, 2016, 23(1): 7073. DOI: 10.3969/j.issn.10078096.2016.01.018.
［11］ 刘标, 周晓军. 非小细胞肺癌免疫组化标志物专家共识(2014)［J］. 临床与实验病理学杂志, 2015, 31(5): 481487. DOI: 10.13315/j.cnki.cjcep.2015.05.001.
［12］ Li L, Li X, Yin J, et al. The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a metaanalysis［J］. PLoS One, 2014, 9(7): e100837. DOI: 10.1371/journal.pone.0100837.
［13］ Turner BM, Cagle PT, Sainz IM, et al. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray［J］. Arch Pathol Lab Med, 2012, 136(2): 163171. DOI: 10.5858/arpa.20110320OA.
［14］ 余何, 李镭, 刘丹, 等. TTF1、NapsinA、P63和CK5/6在肺癌组织的表达与分型诊断的价值［J］. 四川大学学报(医学版), 2017, 48(3): 336341. DOI: 10.13464/j.scuxbyxb.2017.03.002.
［15］ Ye J, FindeisHosey JJ, Yang Q, et al. Combination of napsin A and TTF1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung［J］. Appl Immunohistochem Mol Morphol, 2011, 19(4): 313317. DOI: 10.1097/PAI.0b013e318205b059.
［16］ Ye J, Hameed O, FindeisHosey JJ, et al. Diagnostic utility of PAX8, TTF1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung［J］. Biotech Histochem, 2012, 87(1): 3034. DOI: 10.3109/10520295.2011.591838.
［17］ Wong S, Hong W, Hui P, et al. Comprehensive analysis of PAX8 expression in epithelial malignancies of the uterine cervix［J］. Int J Gynecol Pathol, 2017, 36(2): 101106. DOI: 10.1097/PGP.0000000000000309.
［18］ 郑绘霞, 肖虹, 杨琴, 等. TTF1 SPB CK7和CK20免疫组织化学染色在鉴别肺原发性腺癌与继发性腺癌中的意义［J］. 中国药物与临床, 2004, 4(8): 629631. DOI: 10.3969/j.issn.16712560.2004.08.021. |
